e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Powerful cohort studies with/without lung function
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Short-term and maintenance oral corticosteroid use for German patients with asthma
C. Nan (Gothenburg, Sweden), R. Lindner (Hessen, Germany), Y. Ilgin (Hessen, Germany), T. Schultz (Berlin, Germany), O. Schmidt (Koblenz, Germany), L. Hinsch Gylvin (Cambridge, United Kingdom), E. Bleecker (Tucson, United States of America)
Source:
International Congress 2019 – Powerful cohort studies with/without lung function
Session:
Powerful cohort studies with/without lung function
Session type:
Oral Presentation
Number:
1583
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Nan (Gothenburg, Sweden), R. Lindner (Hessen, Germany), Y. Ilgin (Hessen, Germany), T. Schultz (Berlin, Germany), O. Schmidt (Koblenz, Germany), L. Hinsch Gylvin (Cambridge, United Kingdom), E. Bleecker (Tucson, United States of America). Late Breaking Abstract - Short-term and maintenance oral corticosteroid use for German patients with asthma. 1583
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Late Breaking Abstract - The burden of intermittent oral corticosteroid use in asthma
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021
Late Breaking Abstract - Impact of maintenance and reliever therapy (MART)-focused asthma guideline on SABA prescriptions
Source: Virtual Congress 2021 – Highlights for primary care in 2021
Year: 2021
Late Breaking Abstract - Cost effectiveness of as-needed budesonide/formoterol vs low-dose ICS maintenance therapy in mild asthma patients: A UK perspective
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019
Late Breaking Abstract - Two-year cumulative oral corticosteroid exposure in severe eosinophilic asthma before and after anti-IL-5 therapy
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Late Breaking Abstract - Difference in clinical outcomes between smoking and non-smoking asthma patients who initiated an ICS or ICS/LABA treatment
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019
Late Breaking Abstract - Adrenal function improvement after oral corticosteroid reduction in benralizumab-treated severe eosinophilic asthma: PONENTE maintenance phase
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
Late Breaking Abstract - Oral corticosteroid (OCS) risk predictor for osteoporosis
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021
Late Breaking Abstract - Overprescription of short-acting beta2-agonists in asthma management? Pharmacy reports from 91,673 patients in Poland
Source: International Congress 2019 – New towards old therapies in airway diseases
Year: 2019
Late Breaking Abstract - Comparative real world effectiveness of triple therapy versus dual bronchodilation in frequently exacerbating patients with COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Late Breaking Abstract - Efficacy of oral prednisolone in patients with stable severe eosinophilic asthma (SEA) treated with Mepolizumab
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Late Breaking Abstract: Fluticasone/salmeterol combination confers significant benefits in smoking asthmatics
Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies
Year: 2010
Late Breaking Abstract - Assessment of physical functioning and handling with Tiotropium/Olodaterol (T/O) in patients with COPD requiring long-acting dual bronchodilation in an Italian cohort of patients.
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
Late Breaking Abstract - Daily physical activity in patients with severe asthma and the effect of anti-IL5 therapy.
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019
Late Breaking Abstract - Oral corticosteroids exposure in a Swedish nationwide asthma population during 2006-2016
Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Year: 2018
Late Breaking Abstract - Comparative analysis of effectiveness of Asthma Control Test-guided treatment versus usual care in patients with asthma from China
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Late Breaking Abstract - Durable clinical benefit of benralizumab following oral corticosteroid reduction: The PONENTE study
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Late Breaking Abstract - Patterns of inhaled corticosteroid-formoterol prescriptions in Poland
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019
Oral corticosteroid prescription in asthma: Swiss situation
Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Year: 2020
Late Breaking Abstract - Prolonged azithromycin maintenance treatment in patients with COPD, a follow-up of the COLUMBUS trial
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019
Late Breaking Abstract - Influence of salbutamol use on symptomatic outcomes with maintenance bronchodilators: a pre-specified analysis of the EMAX trial
Source: International Congress 2019 – New towards old therapies in airway diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept